Skip to content

Randomised controlled trial to explore the efficacy of adjuvant homoeopathy in the treatment of COPD patients: an interventional, prospective study

Randomized control Trial to explore the efficacy of adjuvant homoeopathy in the treatment of COPD patients: an interventional, prospective study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083823
Enrollment
60
Registered
2025-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine as an adjunt to Standard treatment of COPD. All patients will take standard allopathic treatment of COPD.: Individualised Homoeopathic Medicine as a

Sponsors

Directorate of AYUSH, Homoeopathic Wing, Government of Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of COPD as per the latest GOLD guidelines. FEV1 more than 50% Willing to participate in the study and agree for treatment compliance. Willingness by the patient to attend scheduled follow up visits and undergo study assessments

Exclusion criteria

Exclusion criteria: Patients not giving consent. Patients with co-morbidity. Patients requiring oxygen therapy and/or hospitalization. Pregnant or lactating mother. Significant metabolic, gastrointestinal, neurological, psychiatric, or endocrine diseases, active malignancy. Patients on any other medication except standard COPD regimen.

Design outcomes

Primary

MeasureTime frame
To compare effect of Homoeopathic add on medicine to standard care treatment of COPD patients, To assess the effect on Spirometry score and to observe any reduction in exacerbation episodes, if anyTimepoint: Nine months

Secondary

MeasureTime frame
Change in symptom scoring at baseline, and completion of treatment as per COPD Assessment Tool (CAT) To assess the incidence of side effects in two groups Timepoint: Nine months

Countries

India

Contacts

Public ContactDR SUDHIR BATRA

Dr MPK Homoeopathic Medical College Hospital and Research Centre Homoeopathy University Jaipur

PMpg2724dept@gmail.com9829053664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026